Strides Pharma Secures USFDA Approval for Celecoxib Capsules, Targeting $116M Market
Strides Pharma Science's Singapore subsidiary has received USFDA approval for Celecoxib Capsules in 100 mg, 200 mg, and 400 mg dosages, strengthening its anti-inflammatory portfolio.